When starting a GLP-1 weight-management medicine, the first weeks often focus on tolerability and routine rather than maximum effect. Approved semaglutide injection schedules begin at a lower dose and increase gradually. Appetite may change before weight does, while nausea, fullness, constipation or diarrhea can occur, especially during dose escalation.
This article is for general educational information and is not a substitute for diagnosis, prescribing, dosing or individualized medical advice. Semaglutide is a prescription medicine. Product indications and instructions differ by formulation. Readers should use the exact current prescribing information and speak with a licensed healthcare professional. |
The first dose is usually not the long-term dose
Approved GLP-1 regimens commonly use titration. For Wegovy injection, current labeling starts at a low weekly dose and increases over several months. The purpose is not to delay results; it is to improve tolerability and reduce gastrointestinal adverse reactions.
Do not treat the starter phase as a reason to speed up on your own.
Appetite changes can be subtle at first
Some people notice less hunger, earlier fullness or less interest in large portions. Others notice very little initially. Both experiences can be compatible with a normal start because response develops over time.
A useful early goal is learning how your body responds rather than comparing your first week with someone else’s third month.
Food choices may need to become more intentional
When appetite falls, it becomes easier to skip meals and harder to fit in enough protein, fluids, fiber and micronutrients. Smaller meals built around nutrient-dense foods can be easier to tolerate than large or very rich meals.
People with diabetes, kidney disease, gastrointestinal conditions or a history of disordered eating need individualized nutrition guidance.
Gastrointestinal effects are common
Nausea, vomiting, diarrhea, constipation and abdominal discomfort are among the most common adverse reactions for semaglutide weight-management treatment. Symptoms can cluster around dose increases.
Contact the prescriber if symptoms are severe, persistent or interfering with hydration. Dehydration can contribute to kidney problems.
Expect follow-up, not a one-time prescription
A good GLP-1 plan includes check-ins. The clinician may review side effects, weight trend, other medicines, glucose if relevant, nutrition and whether the next dose step is appropriate.
Long-term treatment decisions should be based on benefit and tolerability, not a fixed social-media timeline.
Frequently Asked Questions
When will I notice semaglutide working?
It varies. Some people notice appetite changes early, while meaningful weight changes usually take longer.
Why does the dose increase slowly?
Gradual escalation is used to reduce gastrointestinal adverse reactions and improve tolerability.
What should I eat when starting a GLP-1?
Focus on nutrient-dense, appropriately portioned meals with adequate protein, fiber and fluids, tailored to your medical needs.
Is nausea normal when starting semaglutide?
Nausea is common, but severe or persistent nausea, vomiting or dehydration should be discussed with a clinician.
